Reducing Ischemia-Reperfusion Injury in Clinical Lung Transplantation

Transplantation Proceedings

Volumn 39, Issue 2, 2007, Pages 489-492

  Bittner, H B ^a   Binner, C ^a   Dahlberg, P ^b   Mohr, F W ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ;

ADULT; ARTICLE; COLD ISCHEMIA; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL OXYGENATION; FEMALE; GRAFT DYSFUNCTION; HUMAN; ISCHEMIA; LOADING DRUG DOSE; LUNG ARTERY PRESSURE; LUNG DISEASE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN DONOR; PRIORITY JOURNAL; REPERFUSION INJURY; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADULT; HUMANS; LUNG TRANSPLANTATION; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REGISTRIES; REOPERATION; REPERFUSION INJURY; RETROSPECTIVE STUDIES;

EID: 33847753466     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.12.005     Document Type: Article

References (18)

1. Taylor D.O., Edwards L.B., Boucek M.M., et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report-2004. J Heart Lung Transplant 7 (2004) 796
2. Cooper J.D., Patterson G.A., Trulock E.P., and Washington University Lung Transplant Group. Results of 131 consecutive single and bilateral lung transplant recipients. J Thorac Cardiovasc Surg 107 (1994) 460
3. Roberts R.F., Nishanian G.P., Carey J.N., et al. Addition of aprotinin to organ preservation solutions decreases lung reperfusion injury. Ann Thorac Surg 66 (1998) 225
4. Rahman A., Ustunda B., Burma O., et al. Does aprotinin reduce lung reperfusion damage after cardiopulmonary bypass?. Eur J Cardiothorac Surg 18 (2000) 583
5. Prekker M.E., Nath D.S., Walker A.R., et al. Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation. J Heart Lung Transplant 25 (2006) 371
6. Egan T.M., Kaiser L.R., and Cooper J.D. Lung transplantation. Curr Probl Sur 26 (1989) 675
7. King R.C., Binns O.A.R., Rodriguez F., et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 69 (2000) 1681
8. Khan S.U., Salloum J., O'Donovan P.B., et al. Acute pulmonary edema after lung transplantation. Chest 116 (1999) 187
9. Fiser S.M., Tribble C.G., Long S.M., et al. Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response. J Thorac Cardiovasc Surg 121 (2001) 1069
10. Jorens P.G., Van Damme J., De Backer W., et al. Interleukin-8 in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS. Cytokine 4 (1992) 592
11. Miotla J.M., Jeffery P.K., and Hellewell P.G. Platelet-activating factor plays a pivotal role in the induction of experimental lung injury. Am J Respir Cell Mol Biol 18 (1998) 197
12. Asimakopoulos G., Thompson R., Nourshargh S., et al. An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation. J Thorac Cardiovasc Surg 120 (2000) 361
13. Gilliland H.E., Armstrong M.A., Uprichard S., et al. The effect of aprotinin on interleukin-8 concentration and leukocyte adhesion molecule expression in an isolated cardiopulmonary bypass system. Anaesthesia 54 (1999) 427
14. Mathias M.A., Tribble C.G., Dietz J.F., et al. Aprotinin improves pulmonary function during reperfusion in an isolated lung model. Ann Thorac Surg 70 (2000) 1671
15. Eren S., Esme H., Balci A.E., et al. The effect of aprotinin on ischemia-reperfusion injury in an in situ normothermic ischemic lung model. Eur J Cardiothorac Surg 23 (2003) 60
16. Bittner H.B., Richter M., Kuntze T., et al. Aprotinin decreases reperfusion injury and allograft dysfunction in clinical lung transplantation. Eur J Cardiothorac Surg 29 (2006) 210
17. Aziz T.M., Burgess M.I., Haselton P.S., et al. Perfadex for clinical lung procurement: is it an advance?. Ann Thorac Surg 75 (2003) 990
18. Nath D.S., Walter A.R., Johnson A.C., et al. Does Perfadex affect outcomes in clinical lung transplantation?. J Heart Lung Transplant 24 (2005) 2243